Henry Schein Inc. closed 6.05% short of its 52-week high of $82.63, which the company achieved on February 27th.

Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Equal-Weight ...

Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The ...

In 2025, nearly 1,100 GKAS events are scheduled to take place throughout the nation, and it is estimated that approximately ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry ... and medical businesses and distributes consumable products, small equipment ...

Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...

Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...